FDA Inspection
Novitium Pharma LLCNovitium Pharma LLC – FDA Inspection, Mar 31, 2023
Record Details
This FDA Inspection record concerns Novitium Pharma LLC, with an inspection on March 31, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 071be200-4a09-4449-947c-fe0d400d5cc8
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1204308
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Novitium Pharma LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 16, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 1, 2024 | Not classified | New Jersey District Office | |
| July 8, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 4, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2018 | Not classified | New Jersey District Office |
Other documents for Novitium Pharma LLC
- FDA Inspection 1230049 - 2024-02-16
- FDA Inspection 1231393 - 2024-02-01
- FDA Inspection 1145707 - 2021-07-08
- FDA Inspection 1080904 - 2019-02-04
- FDA Inspection 1067953 - 2018-09-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.